Options
Association of Resistin Gene Polymorphisms with Oral Squamous Cell Carcinoma Progression and Development
Journal
BioMed Research International
Journal Volume
2018
Start Page
1-8
ISSN
2314-6133
2314-6141
Date Issued
2018-10-14
Author(s)
Abstract
<jats:p>Oral squamous cell carcinoma (OSCC) accounts for over 90% of malignant neoplasms of the mouth. In Taiwan, OSCC is the fourth most common male cancer and the fourth leading cause of male cancer death. Resistin (<jats:italic>RETN</jats:italic>) is an adipokine that is associated with obesity, inflammation, and various cancers. Here, we examine the association between four single nucleotide polymorphisms (SNPs) of the<jats:italic>RETN</jats:italic>gene (rs3745367, rs7408174, rs1862513, and rs3219175) and OSCC susceptibility as well as clinical outcomes in 935 patients with OSCC and in 1200 cancer-free healthy controls. We found that, in 1465 smokers,<jats:italic>RETN</jats:italic>polymorphisms carriers with the betel-nut chewing habit had a 6.708–10.882-fold greater risk of having OSCC compared to<jats:italic>RETN</jats:italic>wild-type carriers without the betel-nut chewing habit. Patients with OSCC who had A/A homozygous of<jats:italic>RETN</jats:italic>rs3219175 polymorphism showed a high risk for an advanced tumor size (> T2), compared to those patients with G/G homozygotes. In addition, A/T/G/G haplotype significantly increased the risks for OSCC by 1.376-fold. This study is the first to examine the risk factors associated with<jats:italic>RETN</jats:italic>SNPs in OSCC progression and development in Taiwan.</jats:p>
Publisher
Wiley
Type
journal-article